BioCentury
ARTICLE | Company News

Crucell, DSM Biologics N.V., Medarex deal

December 24, 2007 8:00 AM UTC

CRXL and its manufacturing partner, DSM, granted MEDX a non-exclusive license to use the PER.C6 cell line for antibody research. Financial terms were not disclosed. ...